5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 31.23▲ | 31.24▲ | 31.24▲ | 31.19▲ | 31.44▼ |
MA10 | 31.36▼ | 31.44▼ | 31.44▼ | 31.40▼ | 31.16▲ |
MA20 | 31.39▼ | 31.29▼ | 31.29▼ | 31.44▼ | 30.37▲ |
MA50 | 29.79▲ | 29.15▲ | 29.15▲ | 31.10▲ | N/A |
MA100 | 28.68▲ | 28.73▲ | 28.75▲ | 30.26▲ | N/A |
MA200 | N/A | N/A | N/A | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.151▼ | -0.170▼ | -0.170▼ | -0.073▼ | 0.182▲ |
RSI | 58.306▲ | 60.154▲ | 60.137▲ | 48.589▼ | 56.933▲ |
STOCH | 30.159 | 28.452 | 28.452 | 31.580 | 80.450▲ |
WILL %R | -58.333 | -58.333 | -58.333 | -63.597 | -27.089 |
CCI | -45.636 | -69.669 | -69.669 | -83.347 | 40.072 |
Tuesday, September 30, 2025 01:35 PM
APLS is expanding SYFOVRE's potential with a phase 2 study combining it with siRNA APLS-3007, aiming to enhance efficacy in geographic atrophy. Read the latest stock analysis here.
|
Friday, September 19, 2025 06:01 AM
The 12-month price targets, analyzed by analysts, offer insights with an average target of $37.89, a high estimate of $47.00, and a low estimate of $25.00. This current average reflects an increase of ...
|
Thursday, September 11, 2025 07:40 AM
Travere Therapeutics TVTX announced that the FDA, following further review of the supplemental new drug application (sNDA) for Filspari (sparsentan) in focal segmental glomerulosclerosis ("FSGS"), has ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/09/25 | 31.215 | 31.221 | 31.04 | 31.221 | 1,700 |
29/09/25 | 31.16 | 31.345 | 31.16 | 31.275 | 1,277 |
26/09/25 | 31.17 | 31.288 | 31.17 | 31.288 | 800 |
25/09/25 | 30.91 | 30.98 | 30.855 | 30.9757 | 1,867 |
24/09/25 | 31.3599 | 31.3599 | 31.19 | 31.19 | 478 |
23/09/25 | 31.667 | 31.667 | 31.49 | 31.553 | 2,500 |
22/09/25 | 31.70 | 31.7552 | 31.581 | 31.7552 | 550 |
19/09/25 | 31.615 | 31.615 | 31.615 | 31.615 | 100 |
18/09/25 | 31.38 | 31.834 | 31.38 | 31.834 | 2,100 |
17/09/25 | 31.3601 | 31.56 | 31.3174 | 31.3174 | 4,017 |
|
|
||||
|
|
||||
|
|